Dr Muddukrishna Badamane Sathyanarayana

Assistant Professor - Senior Scale

Department of Pharmaceutical Quality Assurance

CURRENT ACADEMIC ROLE & RESPONSIBILITIES

    Muddukrishna Badamane Sathyanarayana is involved in planning and organising day-to-day research activities.

    He participates actively in scientific investigation and learning research techniques. He supervises analytical work and documentation as per pharmaceutical industry regulations. 

 

SUBJECTS CURRENTLY TEACHING

Subject Subject code Semester
Pharmaceutical Analysis PD- 3.2 Third year PharmD
Pharmaceutical Analysis Lab PD-3.2(L) Third year PharmD
Quality Management Systems PQA-MQA 102(T) MPharm- First semester
Pharmaceutical Quality Assurance practicals PQA-MQA 105(P) MPharm- First semester

ACADEMIC QUALIFICATIONS

Degree Specialisation Institute Year of passing
Ph.D. Pharmaceutical Sciences Manipal Academy of Higher Education 2017
MPharm (Master in Pharmacy) Pharmaceutical Analysis and Pharmaceutical Chemistry Rajiv Gandhi University of Health Sciences, Bangalore 2009

Experience

Institution / Organisation Designation Role Tenure
Department of Pharmaceutical Quality Assurance, MCOPS, Manipal Academy of Higher Education Lecturer July 2009-Januray 2013

AREAS OF INTEREST, EXPERTISE AND RESEARCH

Area of Expertise

Co Crystal Technology, Solubility Enhancement, Pharmacokinetic Studies, Stability Indicating Assay Methods

Professional Affiliations & Contributions

Muddukrishna has a strong track record in research both in industry and academics, He is an asset for any institution with his nearly 15+ years of exposure in Research & Development, Laboratory Operations & Quality Assurance in an organization of high repute.  

Presently he is focused in the synthesis and characterization of pharmaceutical materials, including synthesis and characterization of cocrystals. Muddukrishna has published articles in various international peer reviewed journals, he is also a reviewer for various Indian and international journals.

The author credentials and citation graphs can be accessed by following platforms,

SCOPUS AUTHOR ID: 55234164200

ORCID ID: orcid.org/0000-0001-6447-5759

GOOGLE SCHOLAR LINK: https://scholar.google.co.in/citations?user=gubxuTQAAAAJ&hl=en

Peer review record can be verified at: PUBLON ID:  publons.com/a/735512/

Connect, collaborate and share your research experience at: RESEARCH GATE LINK: https://www.researchgate.net/profile/Muddu_Krishna3

MENDELEY LINK: https://www.mendeley.com/profiles/muddukrishna-badamane-sathyanarayan/

Work Experience

Organisation Role Tenure
Bangalore Pharmaceuticals and Research Laboratories, Bangalore Quality Control Executive
ZydusCadila Research Centre, Bangalore Assistant Manager - Analytical Development
EcronAcuNova, Manipal Assistant Manager - Bio analytical department
Stabicon Life Sciences, Bangalore Manager - Analytical Development

Fabrication, solid state characterization and bioavailability assessment of stable binary amorphous phases of Ritonavir with Quercetin

2015-15-01 Swapnil Jayant Dengale Syed Sajjad Hussen Muddukrishna Badamane Sathyanarayana Prashant B. Musmade G Gautham Shenoy Krishnamurthy Bhat

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 89, Impact factor: 4.394

Preparation and characterization of co-amorphous Ritonavir–Indomethacin systems by solvent evaporation technique: Improved dissolution behaviour and physical stability without evidence of intermolecular interactions

2014-15-06 Swapnil Jayant Dengale Om Prakash Ranjan Syed Sajjad Hussen Muddukrishna Badamane Sathyanarayana G Gautham Shenoy Krishnamurthy Bhat

European Journal of Pharmaceutical Sciences, Vol.62, Impact factor: 3.463

Estimation of Stavudine, Lamivudine and Nevirapine by Chemometric UV Spectroscopic Method.

2012-01-01 Abhilasha Gupta Bhagawati ST Muddukrishna Badamane Sathyanarayana Jagadish P C Krishnamurthy Bhat

Indian Journal of Pharmaceutical Education and Research, Vol.4, Impact Factor: 0.54

Development of a sensitive bioanalytical method for the quantification of lacosamide in rat plasma.

2012-01-01 Shah SK SG Vasantharaju Karthik A Muddukrishna Badamane Sathyanarayana Desai N.

Arzneimittelforschung, Vol.62, Impact Factor: 0.50

Preparation and Solid State Characterization of Paclitaxel Cocrystals.

2014-01-01 Muddukrishna Badamane Sathyanarayana Krishnamurthy Bhat G Gautham Shenoy

Research Journal of Pharmacy and Technology, Vol. 7

Regulatory insights for filling variation and managing post approval CMC changes: comparison of latest US FDA and EMA guidelines and an outlook on other international and emerging markets

Drug Regulatory Affairs Shagufta Khan

MPharm II (Drug Regulatory Affairs) 2014-15

Regulatory requirement for product submission in MEA countries and general checklist of CMC data for ROW.

Drug Regulatory Affairs Kushal Bohra

MPharm II (Drug Regulatory Affairs) 2014-15

Introspective study of newly adopted bioequivalence guidance by EU regulatory on MR products, Canadian Regulatory on Comparative bioavailability studies and ANDA submissions ; Refuse to receive standards by USFDA, A comparative insights

Drug Regulatory Affairs Ankita Rastogi

MPharm II (Drug Regulatory Affairs) 2014-15

Stability indicating method for the estimation of saroglitazar in bulk drug and in pharmaceutical formulation by RP-HPLC

Pharmaceutical Quality Assurance Purva Gupta

MPharm II (Pharmaceutical Quality Assurance) 2014-15

Stability indicating assay method development and validation of Aprepitant by RP-HPLC

Pharmaceutical Quality Assurance Raghavendra B.

MPharm II (Pharmaceutical Quality Assurance) 2014-15